AdvaMed State Policy Briefing: PFAS – Background, Basics, and State Policy

Each year in the U.S., ethylene oxide sterilizes 20 billion medical devices, which are critical to preventing serious, even life-threatening, infections.

AdvaMed, the largest global trade organization representing medical technology companies, released the medtech industry’s “Medical Innovation Agenda for the 118th Congress.” These policy priorities would advance AdvaMed’s goal to help usher in a new era of health care innovation on behalf of all American patients. 

AdvaMed’s medtech priorities for the 118th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.

AdvaMed held a panel discussion with two member company experts on product stewardship and environmental sustainability.

The Advanced Medical Technology Association (AdvaMed), the largest trade association representing medical device manufacturers, including all major radiation therapy manufacturers in the U.S. and abroad. released the following statement from President and CEO Scott Whitaker in response to President Biden’s Cancer Moonshot commitment in the annual State of the Union Address.

A lack of public information persists about sterilizing medical devices with ethylene oxide gas. That’s why Scott Whitaker talked with Dr. Lucy Fraiser, a board-certified toxicologist, about the facts.

From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a year like no other.

The year-end spending package making its way through Congress includes key provisions championed by the Advanced Medical Technology Association (AdvaMed) that will benefit the patients served by the medical technology companies AdvaMed represents.